Skip to main content

Advertisement

Patient information, education and self-management in bronchiectasis: facilitating improvements to optimise health outcomes

Article metrics

Abstract

Background

Bronchiectasis is an incurable lung disease characterised by irreversible airway dilatation. It causes symptoms including chronic productive cough, dyspnoea, and recurrent respiratory infections often requiring hospital admission. Fatigue and reductions in quality of life are also reported in bronchiectasis. Patients often require multi-modal treatments that can be burdensome, leading to issues with adherence. In this article we review the provision of, and requirement for, education and information in bronchiectasis.

Discussion

To date, little research has been undertaken to improve self-management in bronchiectasis in comparison to other chronic conditions, such as COPD, for which there has been a wealth of recent developments. Qualitative work has begun to establish that information deficit is one of the potential barriers to self-management, and that patients feel having credible information is fundamental when learning to live with and manage bronchiectasis. Emerging research offers some insights into ways of improving treatment adherence and approaches to self-management education; highlighting ways of addressing the specific unmet information needs of patients and their families who are living with bronchiectasis.

Conclusions

We propose non-pharmacological recommendations to optimise patient self-management and symptom recognition; with the aim of facilitating measurable improvements in health outcomes for patients with bronchiectasis.

Background

Bronchiectasis is a chronic lung condition that leads to a significant symptom and treatment burden for those affected, and significant costs to healthcare services such as the National Health Service. Worldwide prevalence is increasing [1,2,3], yet the evidence base for the management of bronchiectasis remains poor [4, 5]. Historically, there has been relatively little research conducted in this field and it is only recently that more attention has been paid to this previously somewhat neglected disease. Improvements in disease management interventions in bronchiectasis are required.

Interventions in bronchiectasis are likely to include better medical therapies, yet it is also apparent that bronchiectasis is a ‘model’ chronic disease in terms of its potential for improvements in self-management. If patients and their carers know how to recognise symptoms of deterioration or exacerbation, and know how and when to take action, this could facilitate improvements in self-management. This in turn has the potential to promote disease stability, reductions in unscheduled presentations to acute health care services and improvements in longer-term health.

Whilst clearly desirable, expecting patients to understand their condition, the treatments used and the implications of not using them appropriately, is potentially challenging. Prior work has demonstrated that patients with bronchiectasis feel more confident with their treatments when they have received information about them in a specialist clinic [6]. Not every patient with bronchiectasis, however, has access to such information or specialist expertise. Despite recommendations for education and personalised management plans for patients with bronchiectasis [4, 7], there remains a lack of information material openly available to patients when compared to other chronic medical and respiratory conditions. For example, patients with chronic obstructive pulmonary disease (COPD) have a number of available resources [8,9,10,11,12]. In order to facilitate self-care, patients need to have accurate and accessible information about their condition, enabling them to recognise and respond to triggers appropriately and understand how their use of self-management could potentially alter their prognosis. Suitable education could lead to a level of self-management that results in clinically and biologically important endpoints in bronchiectasis. In this article we review the need for education and information in bronchiectasis and its current provision. We discuss options for future improvements in resource development to facilitate much needed improvements in health outcomes.

The burden of bronchiectasis: symptoms, prevalence and treatments

Bronchiectasis leads to symptoms of breathlessness, cough and a chronic infective syndrome and consequently, a poorer quality of life [13, 14] and clinically significant fatigue [15, 16]. Patients often have recurrent infective exacerbations, some of which result in costly hospital admissions. Patients with bronchiectasis are at an increased risk of anxiety and depression [17,18,19]. In cystic fibrosis, depression and anxiety rates are higher than in the general population, and therefore annual screening is recommended [20, 21]. Given the potential for such psychological distress to impact upon adherence and disease management, annual screening in bronchiectasis could also be of benefit. New data has additionally shown a greater risk of coronary heart disease and stroke in patients with bronchiectasis [22]. Multiple comorbidities are common in bronchiectasis [23]. The burden of disease for patients and carers is clearly significant.

The burden of bronchiectasis for healthcare services is also significant. Recently, UK data reported a prevalence of between 43.4/100,000 in those aged 18–30 and 1239.7/100,000 in those aged 70–79 [1]. There is further evidence that prevalence is increasing worldwide [2, 3]. Additionally, HRCT imaging studies report that up to 50% of patients with COPD have co-existent bronchiectasis [24, 25] and it has been proposed that COPD and bronchiectasis can co-exist as ‘bronchiectasis COPD overlap syndrome’ (BCOS) [26]. With approximately 1,000,000 patients with a diagnosis of COPD in the UK alone, [27] there is potential for the rise in prevalence of both bronchiectasis and BCOS to continue.

Bronchiectasis mortality rates have been reported in the UK as twice that of the general population [1], approximately 50% higher than that of uncomplicated COPD (calculated at 3% per annum) and are increasing [28, 29]. The presence of BCOS also leads to higher mortality rates [30,31,32]. Prognosis varies in bronchiectasis, with a study of 91 patients finding that the primary cause of death was usually respiratory, with survival rates of 91% at 4 years and 68.3% at 12.3 years [33]. The same study found factors such as chronic infection with Pseudomonas aeruginosa increase mortality. Two severity scores have been recently developed for use in bronchiectasis: the bronchiectasis severity index (BSI) [34] and the FACED score [35]. Although both predict mortality, the BSI is also predictive of severe exacerbations, hospital admissions and quality of life [36, 37]. Infective exacerbations lead to significant morbidity in bronchiectasis. The British Thoracic Society (BTS) national bronchiectasis audit reported that 38% of patients had three or more exacerbations per year [38]. Within cohorts of patients across Europe, reported average exacerbation rates have been from 1 to 4 per year [36, 39]. This is also consistent with American data on the increasing burden of bronchiectasis [40].

Earlier UK data also emphasised the burden of bronchiectasis, uncertainties in aetiology and lack of evidence for the treatments that are often used [41]. Although there are guidelines for investigation, diagnosis and management of bronchiectasis produced by the BTS, there is no cure for bronchiectasis and many therapies are empiric and not evidence based [4]. Bronchiectasis differs from some chronic diseases in both its periods of exacerbation and the role patients may play in managing these. In bronchiectasis, correct, timely recognition of exacerbation symptoms and prompt, appropriate management of infections could lead to increased disease stability. Failure to commence antibiotics promptly could result in a more severe exacerbation of bronchiectasis, potentially requiring hospital admission. This would lead to significant additional healthcare costs, and a much greater physical, psychological and social impact on patients and their families. Conversely, inappropriate and excessive antibiotic use can lead to antibiotic resistance. This could also have problematic repercussions in terms of response to future treatments and consequently longer-term health outcomes. Facilitating patients’ understanding and ability to self-manage is therefore extremely important.

With some exceptions, treatments are broadly similar regardless of the aetiology of bronchiectasis, but specific treatment plans are tailored to the individual. These can range from no regular treatments at all, to daily use of nebulised therapies in conjunction with physiotherapy, inhalers and oral medications that collectively can be significantly complex and time-consuming for patients and their families. There is evidence that adhering to inhaled antibiotics decreases exacerbation rate and that poor adherence is associated with poorer outcomes [42, 43]. Understanding the importance of a variety of treatments can be problematic for patients and their families and suitable information and education is required to encourage adherence to mutually agreed treatment plans. Importantly, it is known that those with more frequent exacerbations suffer not only the physical effects, but also a reduction in quality of life [14]. Measuring how the psychological impacts and co-morbidities of bronchiectasis affect treatment adherence and self-management behaviours is a key challenge.

Current provision of information for patients with bronchiectasis

The education of patients with bronchiectasis is recommended; including explanations of the disease, recognition and importance of exacerbations, treatment approaches and a personal management plan [4, 7]. Although patients with bronchiectasis gain information through discussion with their clinician, there is relatively little additional information available to them in comparison to the number of resources available for other chronic conditions such as COPD or Cystic Fibrosis. When searching online for information about bronchiectasis, there are resources available. Some are produced by governmental bodies (e.g. the UK National Health Service (NHS) and the US National Institutes of Health), others by health information providers, and by hospitals and charitable organisations [44,45,46,47,48]. However, in addition to being limited in number when compared to other conditions, many are either very brief, with limited information provided, or are lengthy and potentially overwhelming. There are some resources run by patients which primarily serve as a patient’s view or online forum rather than an information resource per se [49, 50]. To date there are no high quality trials nor systematic reviews of such information provision in bronchiectasis, as conducted in COPD [8,9,10,11,12, 51].

A tabulated summary (Table 1) shows examples of some of the bronchiectasis information resources that are available online. Determining credibility (affiliation with a well-known lung charity or a national healthcare provider, for example) is a necessary step in the selection process for patients seeking health information [52]. Despite the available information online, patients and carers with bronchiectasis have reported a lack of trustworthy and user-friendly information and felt they would benefit from credible, multi-format (text, images and video content) resources that they could continue to access outside of a clinic setting [53]. Further identification of the unmet information needs of affected individuals and preferred information formats would enable appropriate resource development. A key priority is to create an accessible, trustworthy resource containing information that users want, rather than information that providers have decided patients should have.

Table 1 A selection of available online bronchiectasis patient information resources (English language)

Provision of information for chronic conditions: General principles and its relationship to self-management

The importance of information provision for patients with long-term conditions and their carers is well recognised. There is longstanding evidence that patients want to access information [54] and that information can reduce anxiety [55] and improve patient outcomes [56, 57]. Self-management is increasingly recognised as an important part of chronic disease management and is recommended by the World Health Organisation (WHO) [58]. Information provision is key to facilitating self-care [59] and inadequacies in information provision are a potential reason for people managing their health poorly [60]. Information provision therefore plays an important role in supporting active participation in care and remains a priority area of health research for all chronic conditions.

Arguably, however, information alone does not always translate into behavioural change [61]. Providing patients with a simple factsheet about their condition is unlikely to result in any major tangible benefits. In a review of the role of education in asthma, it was recognised that information about asthma should not simply be factual but allow patients to acquire skills [62]. It is preferable to teach patients about their asthma treatments and inflammation rather than the structure and function of the lungs, for example [63]. Theoretical constructs and behavioural change techniques beyond information delivery are important to consider in development of any intervention that aims to produce changes in behaviour [64, 65]. Framing information, by establishing what is relevant to the patient group, and how it could be delivered in order to achieve the desired effects is therefore essential. For example, video demonstrations or instructions on how to perform certain tasks in bronchiectasis management such as chest clearance has been identified by patients as a priority [53]. This provision of instruction and demonstration of behaviours is in keeping with social-cognitive theory [66]. Information on behaviour-health links and consequences of actions or inactions, would be in keeping with an information-motivation-behavioural skills model [67]. Information is an intervention, the production of which is a highly skilled process and ideally resources should be user tested, co-designed and co-produced where possible [68]. Such an approach should be taken to resource development for bronchiectasis [69].

Self-management and patient information provision are seemingly inextricably linked. In primary care, self-management has been referred to as ‘patients with chronic disease making day to day decisions about their illnesses’ [70] and ‘the everyday tasks and activities that a person living with a chronic condition needs to carry out’ [71]. The aim in supporting self-management is to allow patients to gain not only the knowledge but also the confidence and relevant skills to manage their condition; promoting patient ‘activation’ [72, 73]. An important concept embedded within this is self-efficacy: the confidence that one can carry out a behaviour necessary to achieve a desired goal [66]. Using self-efficacy as a measurable outcome, however, is not without flaws, as was shown when trialling the expert patient programme (EPP) [74,75,76]. The EPP was initially developed for patients with arthritis and designed to enhance disease specific information rather than replace it, as the programme is generic in nature. Although these studies found improvements in symptom control, pain and hospitalisations as well as gains in self-efficacy, there are some criticisms of the EPP. These include self-efficacy gains not leading to improvements in self-management and not necessarily reducing hospital presentations. Additionally, it has been suggested that participants in EPP studies were not representative of the general population and were possibly better at self-managing than most [77,78,79]. A UK study using a lay-led EPP (n = 629) showed an increase in participant self-efficacy and energy, yet no reduction in health care utilisation [80].

A number of self-management educational resources have been produced for chronic lung conditions other than bronchiectasis. For example, SPACE for COPD, a six week intervention [51]. At 6 months, there were gains in disease knowledge, anxiety and performance levels, yet the primary outcome measure of dyspnoea had not improved [9]. Living Well with COPD [10] is a website with information and videos requiring a password obtained by patients from their physician in order to access the full material. A two year randomised controlled trial conducted in primary care did not show long term benefits over usual care when using measures of self-efficacy and quality of life. The group with access to the living well programme, however, did seem more able to manage their exacerbations [81]. In asthma, a study using an educational programme based on repeated short interventions (face to face sessions at 3 month intervals over 1 year, a personalised action plan and inhaler technique training) saw improvements in asthma control in the intervention group, yet a degree of improvement within the control group was noted too [82]. Cost effectiveness was not examined and although the intervention was brief, it would involve staff time at considerable cost, and there was no provision for patient information needs at other time points.

Systematic reviews of such self-management education in chronic lung disease have also been conducted. A review of eight studies in COPD revealed inconclusive evidence of any benefits [12]. A more recent review and meta-synthesis, however, concluded that self-management education could reduce hospital admissions in COPD, and improve disease knowledge and quality of life. It did not lead to reductions in mortality or smoking rates, nor improve dyspnoea or lung function [11]. A recent systematic review and meta-analysis across different disease areas concluded that self-management interventions can be implemented without a detrimental effect on health outcomes and that they reduce service utilisation [57]. Although the effect sizes were small overall, it is of note that respiratory conditions were amongst the two groups that had the strongest evidence of benefit. In asthma, a Cochrane review reported that self-management education could improve health outcomes only when delivered in conjunction with medical reviews and a written action plan [83]. In cystic fibrosis, there were too few data to draw firm conclusions about recommendations for self-management [84]. In addition, a separate review of psychological interventions in cystic fibrosis highlighted that behavioural interventions had some effect in improving nutrition, and decision making tools regarding transplantation improved knowledge and expectations of transplant, yet there remained insufficient evidence overall [85]. A protocol for a systematic review of self-management in non-cystic fibrosis bronchiectasis has recently been published [86]. Conclusions are likely to be limited, however, reflecting the limited available literature on self-management in bronchiectasis.

Facilitating self-management in bronchiectasis: Use of information and considerations for resource development

An evidence-based intervention for use in bronchiectasis is still needed. In a study using focus groups, patients with bronchiectasis perceived lack of information and confidence as barriers to self-management and felt that disease specific information would be useful [87]. The use of an EPP as part of a self-management programme for patients with bronchiectasis has also been investigated [88]. The programme consisted of two group sessions of disease-specific information followed by a standard, generic EPP for six weeks. Improvement was found in six of ten domains of a self-efficacy scale, including managing symptoms and depression. The intervention group, however, also reported more symptoms and reduced quality of life post intervention. The educational sessions about bronchiectasis were not patient-driven in terms of content or format of delivery, and participants commented that the sessions should be condensed and be attended by physicians. Costs, staffing, time and patient commitment involved with such a course are considerable, making it potentially unfeasible to deliver at scale within a clinical setting. A successful intervention for bronchiectasis would need to meet patients’ needs, be easily accessible and be feasibly deliverable on a long-term basis.

Another recent study has taken a different approach to aiding self-management in patients with bronchiectasis, using a novel tool, the Bronchiectasis Empowerment Tool [89]. The tool consisted of a one page action plan, within a pack containing information and optional notepads. The reported aim of the study was to work alongside existing care in order to improve self-management. At the time of writing the study is closed to recruitment but no published results are available.

In bronchiectasis, self-management includes making decisions surrounding adherence to treatments. Factors predicting adherence to treatments could include beliefs about treatments and burden of treatment [90]. Based on these findings, a theoretical approach is being used to work towards development of a behaviour change intervention to promote treatment adherence [91]. The need for information was again reported by patients during interviews. Participants thought that having knowledge about bronchiectasis and treatments improved adherence.

There is evidence, in COPD, that gaps in knowledge of health care professionals can impact upon patients’ knowledge and understanding of their condition [92]. This finding may apply to other conditions. Patients who have bronchiectasis may not attend a specialist service, and general physicians may have less disease-specific knowledge than a specialist delivering a bronchiectasis service. In addition, they may not have sufficient exposure to have developed specific expertise in exchanging disease-specific information in a patient-focussed manner. Given this relative lack of exposure to patients who have bronchiectasis, further development of such skills in an area outside a healthcare providers’ area of main expertise is likely to be problematic. In exploratory interviews with patients who had bronchiectasis, [52] participants referred to the fact that they had very little information until they started to attend a specialist bronchiectasis clinic. A trustworthy and patient-driven resource would enable both dissemination of good practice and equity of information access amongst the patient group.

Information seeking is another important aspect to consider in developing an understanding of patients’ information needs and how such needs are fulfilled. Trust, particularly in relation to online resources, is a recognised issue [93, 94]. Reasons identified for avoiding seeking information in patients with bronchiectasis include not trusting sources, and fear of what they may find [52]. The potential for information to worsen rather than reduce anxiety has been proposed [95], and the concept of information avoidance is recognised [96]. Reviews of health information seeking behaviour have concluded that a better understanding of this concept will enable the provision of better information, and that information should meet patients’ individual needs [95, 96]. Previous work exploring why patients with cancer may not want or seek information about their condition also identified that patients’ attitudes and coping strategies can limit their seeking of information [97]. The importance of identifying the diversity of needs of the patient group in order to tailor resources to suit them rather than assume a ‘one size fits all’ approach will be effective was additionally highlighted. Having an in depth understanding of the information and education needs of both patients and their families, and how these could be met, in addition to an appreciation of how, why and when patients seek information would appear to be fundamental to the development and execution of novel interventions in bronchiectasis. Understanding these needs across a broad sample of potential users with differing backgrounds, ages and disease severities, for example, is also important. Those with bronchiectasis aetiologies that are associated with additional management challenges or poorer outcomes, for example, non-tuberculous mycobacterium infections, bronchiectasis-COPD overlap syndrome (BCOS) [26] and bronchiectasis rheumatoid arthritis syndrome (BROS) [98] may benefit from supplementary educational resources specific to their needs.

Patients use information to aid their decision making about various aspects of their management. Carers are often involved in shared decision-making in a variety of different ways and patients are rarely entirely autonomous in these processes [99, 100]. The role of family or carers in the adaptation of patients and coping with chronic illness is very important [101, 102]. Carers are just as likely to engage with information resources as patients. Therefore, any newly developed resource should accommodate the needs of carers and families of patients with bronchiectasis in addition to patients. A meta-synthesis of qualitative studies highlighted the importance of social networks (family, friends, communities) in the self-management of chronic illnesses [103]. A longitudinal study of patients with heart disease and diabetes also acknowledges this role of social networks in supporting self-management [104]. Participation in community organisations (including online communities and health education groups) has been associated with better physical and mental health within the self-management of diabetes [105, 106]. It is apparent that when considering educational and self-management support interventions they need to be tailored to users’ approaches.

Work has begun in bronchiectasis, as yet published only in abstract form, to identify the unmet needs of patients and carers living with bronchiectasis, and co-develop a multi-format information resource [53, 107]. A feasibility study carried out using a resource developed with users, based on their needs and experiences, included user evaluations of the resource and web analytics [108]. A particular feature of this resource is the use of video in information delivery, from professionals, patients and carers. This use of video was based on the findings of prior qualitative interviews and was found to be a particularly engaging aspect of the resource [69, 109]. The website (www.bronchiectasis.me) had over 27,000 worldwide views during the study period of 16 months. By delivering interventions that have been designed in conjunction with patients, to complement their learning approaches, information resources can be tailored to meet needs and optimise uptake.

Conclusions

Patients and carers living with bronchiectasis have been relatively poorly provided for in terms of health information and self-management guidance, despite clear potential for such interventions to produce tangible benefits for patients and health care service providers. The prevalence of bronchiectasis is rising and makes this issue ever more pressing. This lack of provision should be addressed with a patient-centred approach, incorporating knowledge of information seeking and self-management in both other chronic diseases and bronchiectasis itself. In order to achieve development of patient-driven and user-friendly resources, the underlying needs and issues surrounding information and its uptake for patients with bronchiectasis must first be fully identified. The implementation of systematic annual screening for depression and anxiety could also identify patients with requirements for additional psychological support.

As with information delivered in a clinic setting, patients’ needs vary. By ensuring the involvement of diverse groups during co-development processes, this range of views can be captured. By developing resources with clearly labelled and sub-sectioned subject areas, users can interact with the information they need, when they need it, and avoid what they may not need or want to know. Using healthcare experts across the multidisciplinary team, patients and carers to co-produce high quality information and education resources is an important step towards facilitating self-management advancements, improvements in adherence and consequent physical and psychological health improvements in bronchiectasis.

Abbreviations

BCOS:

Bronchiectasis COPD overlap syndrome

BLF:

British Lung Foundation

BROS:

Bronchiectasis rheumatoid arthritis syndrome

BSI:

Bronchiectasis severity index

BTS:

British Thoracic Society

COPD:

Chronic obstructive pulmonary disease

EPP:

Expert patient programme

HRCT:

High resolution computed tomography

NHS:

National Health Service

UK:

United Kingdom

WHO:

World Health Organisation

References

  1. 1.

    Quint JK, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004-2013: a population based cohort study. Eur Respir J. 2016;47(1):186–93.

  2. 2.

    Ringshausen FC, et al. Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J. 2015;46:1805–7.

  3. 3.

    Seitz AE, et al. Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007. Chest. 2012;142:432–9.

  4. 4.

    Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65(Suppl 1):i1–58.

  5. 5.

    Hester KLM, McDonnell MJ, De Soyza A. Bronchiectasis: what we don't know yet but should. BRN Rev. 2016;2(1):14–26.

  6. 6.

    Hester KLM, McAlinden P, De Soyza A. Education and information for patients with bronchiectasis: what do patients want? Eur Respir J. 2011;38(supplement 35):P3622.

  7. 7.

    Bronchiectasis Quality Standards Working Group. Quality Standards for clinically significant bronchiectasis in adults. Br Thorac Soc Rep. 2012;4(1). ISSN 2040-2023.

  8. 8.

    Apps LD, et al. The development and pilot testing of the self-management programme of activity, coping and education for chronic obstructive pulmonary disease (SPACE for COPD). Int J ChronObstruct Pulmon Dis. 2013;8:317–27.

  9. 9.

    Mitchell KE, et al. A self-management programme for COPD: a randomised controlled trial. Eur Respir J. 2014;44(6):1538–47.

  10. 10.

    McGill University Health Centre and Quebec Asthma and COPD Network. Living well with COPD a plan of action for life. 2013 09042013]; Available from: http://www.livingwellwithcopd.com/.

  11. 11.

    Wang T, et al. Effectiveness of disease-specific self-management education on health outcomes in patients with chronic obstructive pulmonary disease: an updated systematic review and meta-analysis. Patient Educ Couns. 2017.

  12. 12.

    Monninkhof EEM, et al. Self-management education for patients with chronic obstructive pulmonary disease: a systematic review. Thorax. 2003;58:394–8.

  13. 13.

    O'Leary CJ, et al. Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respir Med. 2002;96(9):686–92.

  14. 14.

    Wilson CB, et al. Validation of the St George's respiratory questionnaire in bronchiectasis. Am J Respir Crit Care Med. 1997;156(2 Pt 1):536–41.

  15. 15.

    Hester KLM, et al. Fatigue in bronchiectasis. Q J Med. 2012;105(3):235–40.

  16. 16.

    Macfarlane JG, et al. Fatigue in bronchiectasis: its relationship to pseudomonas colonisation, dyspnoea and airflow obstruction. Thorax. 2010;65:A60.

  17. 17.

    Ozgun Niksarlioglu EY, et al. Factors related to depression and anxiety in adults with bronchiectasis. Neuropsychiatr Dis Treat. 2016;12:3005–10.

  18. 18.

    Boussoffara L, et al. Anxiety-depressive disorders and bronchiectasis. Rev Mal Respir. 2014;31(3):230–6.

  19. 19.

    Olveira C, et al. Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life. Qual Life Res. 2013;22(3):597–605.

  20. 20.

    Quittner AL, et al. Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of the international depression epidemiological study across nine countries. Thorax. 2014;0:1–8.

  21. 21.

    Quittner AL, et al. International committee on mental health in cystic fibrosis: Cystic Fibrosis Foundation and European cystic fibrosis society consensus statements for screening and treating depression and anxiety. Thorax. 2016;71:26–34.

  22. 22.

    Navaratman V, et al. Bronchiectasis and the risk of cardiovascular disease: a population-based study. Thorax. 2017;72:161–6.

  23. 23.

    McDonnell MJ, et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med. 2016;4(12):969–79.

  24. 24.

    Patel IS, et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Critical Care Medicine. 2004;170(4):400–7.

  25. 25.

    O'Brien C, Guest PJ, Hill SL. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax. 2000;55:635–42.

  26. 26.

    Hurst JR, Elborn JS, De Soyza A. COPD-bronchiectasis overlap syndrome. Eur Respir J. 2015;45:310–3.

  27. 27.

    Shahab L, et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61(12):1043–7.

  28. 28.

    Roberts HJ, Hubbard R. Trends in bronchiectasis mortality in England and Wales. Respir Med. 2010;104(7):981–5.

  29. 29.

    Office for National Statistics, Mortality Statistics by cause. Series DH2. 2004, London: The Stationary Office.

  30. 30.

    Gatheral T, et al. COPD-related bronchiectasis; independent impact on disease course and outcomes. COPD. 2014;11:605–14.

  31. 31.

    Goeminne PC, et al. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort anlaysis. Respir Med. 2014;108:287–96.

  32. 32.

    De Soyza A, et al. Bronchiectasis rheumatoid overlap syndrome (BROS) is an independent risk factor for mortality in patients with bronchiectasis: a multicentre cohort study. Chest. 2017;151(6):1247-54.

  33. 33.

    Loebinger MR, et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J. 2009;34(4):843–9.

  34. 34.

    Chalmers JD, et al. The bronchiectasis severity index an international derivation and validation study. Am J Respir Critic Care Med. 2014;189(5):576–85.

  35. 35.

    Martinez-Garcia MA, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J. 2014;43:1357–67.

  36. 36.

    McDonnell MJ, et al. Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts. Thorax. 2016;71:1110–8.

  37. 37.

    Ellis HC, et al. Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study. Eur Respir J. 2016;47:482–9.

  38. 38.

    Hill AT, Routh C, Welham S. National BTS bronchiectasis audit 2012: is the quality standard being adhered to in adult secondary care? Thorax. 2013;0:1–3.

  39. 39.

    McDonnell MJ, et al. Non cystic fibrosis bronchiectasis: a longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance. Respir Med. 2015;109(6):716–26.

  40. 40.

    Seitz AE, et al. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest. 2010;138(4):944–9.

  41. 41.

    Kelly MG, Murphy S, Elborn JS. Bronchiectasis in secondary care: a comprehensive profile of a neglected disease. Eur J Intern Med. 2003;14(8):488–92.

  42. 42.

    McCullough AR, et al. Treatment adherence and health outcomes in patients with bronchiectasis. BMC Pulmon Med. 2014;14:107.

  43. 43.

    Haworth CS, et al. Inhaled colistin in patients with bronchiectasis and chronic pseudomonas infection. Am J Respir Crit Care Med. 2014;189(8):975–82.

  44. 44.

    Newcastle upon Tyne Hospitals NHS Foundation Trust. Bronchiectasis Service. 2015 [cited 2016; Available from: http://www.newcastle-hospitals.org.uk/services/cardiothoracic_services_bronchiectasis.aspx.

  45. 45.

    Patient.co.uk. Bronchiectasis. 2016 [cited 2016; Available from: http://patient.info/health/bronchiectasis-leaflet.

  46. 46.

    NHS Choices. Bronchiectasis. 2015 [cited 2016; Available from: http://www.nhs.uk/conditions/Bronchiectasis/Pages/Introduction.aspx.

  47. 47.

    National Heart Lung and Blood Institute. What is bronchiectasis? 2014; Available from: https://www.nhlbi.nih.gov/health/health-topics/topics/brn.

  48. 48.

    British Lung Foundation. Bronchiectasis. 2015 [cited 2016; Available from: https://www.blf.org.uk/support-for-you/bronchiectasis.

  49. 49.

    Angel. Bronchiectasis R Us. 2015 [cited 2015; Available from: http://www.bronchiectasis.info/.

  50. 50.

    Hunter, R. Bronchiectasis Help 2015 cited 2015; Available from: http://www.bronchiectasishelp.org.uk/.

  51. 51.

    Mitchell-Wagg K, et al. A self-management program of activity coping and exercise (SPACE) for COPD: results from a randomised controlled trial. Thorax. 2012;67 supplement II:A25.

  52. 52.

    Hester KLM, De Soyza A, Rapley T. Information and education needs of patients with bronchiectasis: a qualitative investigation. Thorax. 2012;67(supplement 2):A141.

  53. 53.

    Hester KLM, et al. Living your life with bronchiectasis: an exploration of patients and carers information needs informing development of a novel information resource. Thorax. 2015;70(Supplement 3):P201.

  54. 54.

    Bunker TD. An information leaflet for surgical patients. Ann R Coll Surg Engl. 1983;65(4):242–3.

  55. 55.

    George CF, Waters WE, Nicholas JA. Prescription information leaflets: a pilot study in general practice. Br Med J (Clin Res Ed). 1983;287(6400):1193–6.

  56. 56.

    Audit Commission, What seems to be the matter: communication between hospitals and patients. HMSO. 1993. ISBN 011886100X.

  57. 57.

    Panagioti M, et al. Self-management support interventions to reduce health care utilisation without compromising outcomes: a systematic review and meta-analysis. BMC Health Serv Res. 2014;14:356.

  58. 58.

    Epping-Jordan JE, et al. Improving the qaulity of health care for chronic conditions. Qual Saf Health Care. 2004;13:299–305.

  59. 59.

    Department of Health, Our health, our care, our say: a new direction for community services. 2006.

  60. 60.

    Wanless, D., Securing good health for the whole population, D.o. health, Editor. 2004, HMSO.

  61. 61.

    Becker MH. In: Shumaker SA, editor. Theoretical models of adherence and strategies for improving adherence, in the handbook of health behaviour change. New York: Springer Publishing Company; 1990. p. 5–43.

  62. 62.

    Partridge MR, Hill SR. Enhancing care for people with asthma: the role of communication, education, training and self-management. Eur Respir J. 2000;16(2):333–48.

  63. 63.

    Takakura S, Hasegawa T, Ishihara K. Assessment of patients' understanding of their asthmatic condition established in an outpatient clinic. Eur Respir J. 1998;12(supplement 29):24S.

  64. 64.

    Abraham C, Michie S. A taxonomy of behaviour change techniques used in interventions. Health Psychol. 2008;27(3):379–87.

  65. 65.

    Michie S, et al. Making psychological theory useful for implementing evidence based practice: a consensus approach on behalf on the "psychological theory" group. Qual Saf Health Care. 2005;14:26–33.

  66. 66.

    Bandura A. Self-efficacy: toward a unifying theory of behavioural change. Psychol Rev. 1977;84(2):191–215.

  67. 67.

    Fisher JD, Fisher WA. Changing AIDS risk behavior. Psychol Bull. 1992;111:455–74.

  68. 68.

    Patient Information Forum, Making the case for information. 2013.

  69. 69.

    Hester KLM, Newton J, Rapley T, et al. Information and education provision in bronchiectasis: co-development and evaluation of a novel patient-driven resource in a digital era. Eur Respir J. 2018;51:1702402. https://doi.org/10.1183/13993003.02402-2017.

  70. 70.

    Bodenheimer T, et al. Patient self-management of disease in primary care. JAMA. 2002;288(19):2469–75.

  71. 71.

    Eaton S, Roberts S, Turner B. Delivering person centred care in long term conditions. BMJ. 2015;350:h181.

  72. 72.

    Hibbard JH, Greene J. What the evidece shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff. 2013;32:207–14.

  73. 73.

    Eaton S. Delivering person-centred care in long-term conditions. Future Hospital Journal. 2016;3(2):128–31.

  74. 74.

    Lorig K, Holman H. Arthritis self-management studies: a twelve-year review. Health Educ Q. 1993;20(1):17–28.

  75. 75.

    Lorig K, et al. Outcomes of self-help education for patients with arthritis. Arthritis Rheum. 1985;28(6):680–5.

  76. 76.

    Lorig KR, et al. Chronic disease self-mangement program: 2-year health status and health care utilization outcomes. Med Care. 2001;39(11):1217–23.

  77. 77.

    Lindsay S, Vrijhoef HJM. A sociological focus on 'expert patients'. Health Sociol Rev. 2009;18(2):139–44.

  78. 78.

    Gately C, Rogers A, Sanders C. Re-thinking the relationship between long-term condition self-management education and the utilisation of health services. Soc Sci Med. 2007;65(5):934–45.

  79. 79.

    Taylor D, Bury M. Chronic illness, expert patients and care transition. Sociology of Health and Illness. 2007;29(1):27–45.

  80. 80.

    Kennedy A, et al. The effectiveness and cost effectiveness of a national lay led self care support programme for patients with long-term conditions: a pragmatic randomised controlled trial. J Epidemiol Community Health. 2007;61(3):254–61.

  81. 81.

    Bischoff E, et al. Comprehensive self-management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial. BMJ. 2012;345:14.

  82. 82.

    Plaza V, et al. A repeated short educational intervention improves asthma control and quality of life. Eur Respir J. 2015;46(5):1298–307.

  83. 83.

    Gibson PG, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane database of Sytematic Reviews. 2003;(1):CD001117.

  84. 84.

    Savage E, et al. Self-management education for cystic fibrosis (review). Cochrane Libr. 2011;7:CD007641.

  85. 85.

    Goldbeck L, et al. Psychological interventions for in dividuals with cystic fibrosis and their families. Cochrane database of Sytematic Reviews. 2014;6:CD003148

  86. 86.

    Kelly C, et al. Self-management for non-cystic fibrosis bronchiectasis. Cochrane Database of Sytematic Reviews. 2017;1:CD012528

  87. 87.

    Lavery K, et al. Self-management in bronchiectasis: the patients' perspective. Eur Respir J. 2007;29(3):541–7.

  88. 88.

    Lavery K, et al. Expert patient self-management program versus usual care in bronchiectasis: a randomized controlled trial. Arch Phys Med Rehabil. 2011;92:1194–201.

  89. 89.

    ISRCTN Registry. Evaluation of Bronchiectasis Empowerment Tool (BET). 2015; Available from: http://www.isrctn.com/ISRCTN18400127.

  90. 90.

    McCullough AR, et al. Predictors of adherence to treatment in bronchiectasis. Respir Med. 2015;109(7):838–45.

  91. 91.

    McCullough AR, et al. Defining the content and delivery of an intervention to change adherence to treatment in bronchiectasis (CAN-BE): a qualitative approach incorporating the theoretical domains framework, behavioural change techniques and stakeholder expert panels. BMC Health Serv Res. 2015;15(1):342.

  92. 92.

    Edwards K, Singh S. The Bristol COPD knowledge questionnaire (BCKQ): assessing the knowledge of healthcare professionals involved in the delivery of COPD services. Thorax. 2012;67(Suppl 2):P235.

  93. 93.

    Henwood F, et al. 'Ignorance is bliss sometimes': constraints on the emergence of the 'informed patient' in the changing landscapes of health information. Sociology of Health and Illness. 2003;25(6):589–607.

  94. 94.

    Zulman D, et al. Trust in the internet as a health resource among older adults:analysis of data from a nationally representative survey. J Med Internet Res. 2011;13(1):e19.

  95. 95.

    Lambert SD, Loiselle CG. Health information--seeking behaviour. Qual Health Res. 2007;17:1006–19.

  96. 96.

    Case DO, et al. Avoiding versus seeking: the relationship of infromation seeking to avoidance, blunting, coping, dissonance and related concepts. Journal of the Medical Library Association. 2005;93(3):353–62.

  97. 97.

    Leydon GM, et al. Cancer patients' information needs and information seeking behaviour: in depth interview study. BMJ. 2000;320(7239):909–13.

  98. 98.

    De Soyza A, et al. Bronchiectasis rheumatoid overlap syndrome is an independent risk factor for mortality in patients with bronchiectasis: a multicenter cohort study. Chest. 2017;151(6):1247–54.

  99. 99.

    Ohlen J, et al. The influence of significant others in complementary and alternative medicine decisions by cancer patients. Soc Sci Med. 2006;63(6):1625–36.

  100. 100.

    Rapley T. Distributed decision making: the anatomy of decisions-in-action. Sociology of Health and Illness. 2008;30(3):429–44.

  101. 101.

    Anderson R, Bury M. Living the chronic illness: the experiences of patients and their families. London: Unwin Hyman; 1988.

  102. 102.

    Heijmans M, de Ridder D, Bensing J. Dissimilarity in patients' and spouses' representations of chronic illness: exploration of relations to patient adaptation. Psychol Health. 1999;14(3):451–66.

  103. 103.

    Vassilev I, et al. The influence of social networks on self-management support: a metasynthesis. BMC Public Health. 2014;14:719.

  104. 104.

    Reeves D, et al. The contribution of social networks to the health and management of patients with long-term conditions: a longitudinal study. PLoS One. 2014;9(6):e98340.

  105. 105.

    Koetsenruijter J, et al. Social support systems as determinants of self-management and quality of life of people with diabetes across Europe: study protocol for an observational study. Health Qual Life Outcomes. 2014;12:29.

  106. 106.

    Koetsenruijter J, et al. Social support and health in diabetes patients: an observational study in six European countries in an era of austerity. PLoS One. 2015;10(8):e0135079.

  107. 107.

    Hester KLM, et al. Living your life with bronchiectasis: an exploration of patients and carers information needs., in British sociological association medical sociology 47th annual conference. York: BSA; 2015. p. P106.

  108. 108.

    Hester KLM, et al. Evaluation of a novel information resource for patients with bronchiectasis: study protocol for a randomised controlled trial. Trials. 2016;17:210.

  109. 109.

    Hester KLM, et al. Evaluation of a novel intervention for patients with bronchiectasis: the bronchiectasis information and education feasibility (BRIEF) study. Thorax. 2016;71(Supplement 3):A265.

Download references

Funding

Katy Hester is funded by a National Institute for Health Research Doctoral Research Fellowship. This article presents independent work funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.

ADS acknowledges funding to the BronchUK network from the UK Medical Research Council (grant MR/L011263/1) and a prior Higher Education Funding Council (HFCE senior lectureship).

Author information

KH is the main author of this review. TR, JN, ADS were contributors to the manuscript and all authors read and approved the final manuscript.

Correspondence to Katy L. M. Hester.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Keywords

  • Bronchiectasis
  • Self-management
  • Information
  • Education
  • Qualitative
  • Adherence